Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China’s Antibiotic API Prices Soar

This article was originally published in PharmAsia News

Executive Summary

The price of the antibiotic azithromycin in China has increased from RMB 850 to RMB 900 per kilogram, following the example of its penicillin counterparts in early February.

The price of the antibiotic azithromycin in China has increased from RMB 850 to RMB 900 per kilogram, following the example of its penicillin counterparts in early February. The gain is caused by the recent stable price of competitor erythromycin and the skyrocketing demand for generics because of the upcoming drug patent expirations. A securities firm researcher predicted the prices of penicillin will rise even further. An industry insider projected that the clinical use of antibiotics would continue to decrease and that downscale antibiotics are more likely to regain popularity due to their low-level drug resistance. (Click Here For More - Chinese Language)

Antibiotic API Prices Robustly High; Downscale Products To Be Popular Again- finance.qq.com (2/29/2012)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC080582

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel